Tag: EMA
European Medicines Agency Withdraws Levamisole Drugs Over Severe Neurological Risks
European Medicines Agency withdraws all levamisole medicines from EU markets due to serious neurological risks identified by safety committee. Nigerian…
EU and US Drug Regulators Split Over AstraZeneca’s New Breast Cancer Treatment
European and American drug regulators reached opposing conclusions on AstraZeneca's experimental breast cancer treatment. The EMA endorsed the antibody-drug conjugate…
Submit Your Paper to GMJ
No APC until January 2027.